Literature DB >> 11692106

Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis.

A Shaida1, G Kenyon, J Devalia, R J Davies, T T MacDonald, S L Pender.   

Abstract

BACKGROUND: Allergic rhinitis and asthma show many similarities in their epithelial and inflammatory responses to allergens. However, one notable difference is that disruption and desquamation of the epithelium is a characteristic feature of asthma, whereas in perennial allergic rhinitis the epithelium is intact and thickened. One reason for this might be differing expression of matrix metalloproteinases (MMPs) or their inhibitors (TIMPs). There are few published data on the presence of MMPs or TIMPs in the nasal mucosa in rhinitis.
OBJECTIVE: The purpose of this study was to investigate MMP and TIMP mRNA and protein in nasal mucosa from subjects with perennial allergic rhinitis and from nonrhinitic control subjects.
METHODS: Biopsy specimens of nasal mucosa were taken from 10 well-characterized subjects with perennial allergic rhinitis and 10 nonrhinitic control subjects. MMP and TIMP mRNA was quantified through use of competitive RT-PCR, and protein was detected by means of Western blotting and ELISA.
RESULTS: TIMP-1 mRNA and TIMP-2 mRNA were present in nasal samples, but there was no significant difference between the 2 groups. Only small amounts of MMP-1, -2, -3, and -9 mRNA were detected in the same samples. The corresponding proteins were detected by means of Western blotting. TIMP-1 protein and TIMP-2 protein were quantified in tissue homogenates; there was no significant difference between the 2 groups.
CONCLUSION: Our studies have demonstrated the presence of large amounts of TIMP-1 and TIMP-2 mRNA and protein in nasal mucosa. There is no upregulation of MMPs or changes in TIMP expression in the nasal mucosa of patients with allergic rhinitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692106     DOI: 10.1067/mai.2001.119024

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  Effectiveness of quercetin in an experimental rat model of allergic rhinitis.

Authors:  Mustafa Sagit; Halil Polat; Seren Gulsen Gurgen; Elife Berk; Sabri Guler; Mehmet Yasar
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-10       Impact factor: 2.503

2.  Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis.

Authors:  Ling-Feng Wang; Chen-Yu Chien; Chih-Feng Tai; Wen-Rei Kuo; Edward Hsi; Suh-Hang Hank Juo
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

3.  Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.

Authors:  V Bjerkeli; B Halvorsen; J K Damås; I Nordøy; A Yndestad; P Aukrust; S S Frøland
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

4.  Rapid intranasal delivery of chloramphenicol acetyltransferase in the active form to different brain regions as a model for enzyme therapy in the CNS.

Authors:  Abhilash P Appu; Peethambaran Arun; Jishnu K S Krishnan; John R Moffett; Aryan M A Namboodiri
Journal:  J Neurosci Methods       Date:  2015-12-10       Impact factor: 2.390

5.  Angiogenic factors play a significant role in nasal airway remodeling in allergic rhinitis.

Authors:  Hun-Jong Dhong
Journal:  Allergy Asthma Immunol Res       Date:  2011-12-12       Impact factor: 5.764

6.  Expression and Roles of MMP-2, MMP-9, MMP-13, TIMP-1, and TIMP-2 in Allergic Nasal Mucosa.

Authors:  Sachiko Mori; Ruby Pawankar; Chika Ozu; Manabu Nonaka; Toshiaki Yagi; Kimihiro Okubo
Journal:  Allergy Asthma Immunol Res       Date:  2012-06-12       Impact factor: 5.764

7.  Comparison of circulating fibrocytes from non-asthmatic patients with seasonal allergic rhinitis between in and out of pollen season samples.

Authors:  Marie-Ève Côté; Marie-Ève Boulay; Sophie Plante; Andréanne Côté; Jamila Chakir; Louis-Philippe Boulet
Journal:  Allergy Asthma Clin Immunol       Date:  2022-03-16       Impact factor: 3.406

8.  Inhibition of angiogenic factor production from murine mast cells by an antiallergic agent (epinastine hydrochloride) in vitro.

Authors:  K Asano; A Furuta; K Kanai; S Sakaue; H Suzaki; T Hisamitsu
Journal:  Mediators Inflamm       Date:  2008       Impact factor: 4.711

9.  Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro.

Authors:  Toshiyuki Shimizu; Kenichi Kanai; Kazuhito Asano; Tadashi Hisamitsu; Harumi Suzaki
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

Review 10.  Remodeling of the lower and upper airways.

Authors:  Guilherme de Toledo Leme Constantino; João Ferreira de Mello
Journal:  Braz J Otorhinolaryngol       Date:  2009 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.